Retinitis Pigmentosa (RP) Completed Phase 1 / 2 Trials for Lutein (DB00137)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00029289Effects of Lutein in Retinitis PigmentosaTreatment